Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN117964632B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117964632B reveals direct fluorination for antitumor drugs. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing.